Viatris Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 17.89B | 16.26B | 15.43B | 14.74B | 14.30B | -3.0% | |
| Cost of Revenue | (12.31B) | (9.77B) | (8.99B) | (9.12B) | (9.29B) | 1.9% | |
Gross Profit | 5.58B | 6.50B | 6.44B | 5.62B | 5.01B | -10.8% | |
| Operating Expenses | |||||||
| Research & Development | (681.00M) | (662.20M) | (805.20M) | (808.70M) | (965.90M) | 19.4% | |
| Selling, General & Administrative | (4.53B) | (4.18B) | (4.65B) | (4.43B) | (3.79B) | -14.3% | |
| Depreciation & Amortization | (4.51B) | (3.03B) | (2.74B) | (2.89B) | (2.80B) | -3.3% | |
Operating Income (EBIT) | -34.00M | 1.61B | 766.20M | 10.10M | -2.66B | -26467.3% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (636.20M) | (592.40M) | (573.10M) | (550.00M) | (471.30M) | -14.3% | |
| Other Income/Expenses (Net) | -630.40M | 1.20B | -563.30M | -633.30M | -1.00B | 58.2% | |
Income Before Tax | -664.40M | 2.81B | 202.90M | -623.20M | -3.67B | 488.1% | |
| Income Tax Expense | (604.70M) | (734.60M) | (148.20M) | (11.00M) | (150.10M) | -1464.5% | |
Net Income | -1.27B | 2.08B | 54.70M | -634.20M | -3.51B | 454.2% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-1 | $2 | $0 | $-1 | $-3 | 466.0% | |
| Weighted Avg Shares Outstanding | 1.21B | 1.21B | 1.20B | 1.19B | 1.17B | -1.9% | |
| Weighted Avg Shares Outstanding (Diluted) | 1.21B | 1.22B | 1.21B | 1.19B | 1.17B | -1.9% | |
EBITDA | 4.48B | 6.43B | 3.52B | 2.82B | -395.40M | -114.0% |
Explore VTRS
VTRS in the Healthcare
Large Cap